RecruitingNot ApplicableNCT06584123

Molecular Pituitary Imaging Using 18F-FET PET

Exploring the Potential for 18F-fluoro-ethyl-tyrosine (18F-FET) to Enable Wider Access to Molecular Imaging for Patients With Pituitary Adenomas (FET-pit-PET Study)

Sponsor

University of Cambridge

Enrollment

20 participants

Start Date

Sep 3, 2024

Study Type

INTERVENTIONAL

Conditions

Pituitary Adenoma

Summary

The goal of this single centre pilot study is to explore whether 18F-fluoro-ethyl-tyrosine PET (FET-PET) yields comparable findings to 11C-methionine PET (Met-PET) for the localisation of pituitary tumours.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new type of PET scan using a radioactive tracer called 18F-FET to better image pituitary tumors (growths at the base of the brain). The goal is to see if this scan can detect tumors more accurately than existing methods. **You may be eligible if...** - You are 18 or older - You have a suspected pituitary adenoma (a non-cancerous pituitary tumor) based on clinical symptoms, lab tests, or imaging - You have previously had a different type of PET scan (11C-Met-PET/CT) - You are willing and able to give informed consent **You may NOT be eligible if...** - You are pregnant or breastfeeding - You have a known allergy to the imaging tracer - You have uncontrolled diabetes - You are unable to lie still for the scan - You have claustrophobia that would prevent you from completing the imaging Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.